1. Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer. Issue 11 (26th February 2022) Authors: Feng, Junru; Lu, Hui; Ma, Wenhao; Tian, Wenjing; Lu, Zhuan; Yang, Hongying; Cai, Yongping; Cai, Pengfei; Sun, Yuchen; Zhou, Zilong; Feng, Jiaqian; Deng, Jiazhong; Shu, Ying; Qu, Kun; Jia, Weidong; Gao, Ping; Zhang, Huafeng Journal: Protein & cell Issue: Volume 13:Issue 11(2022) Page Start: 825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗